Pharmaceutical companies are creating even more potent weight-loss medications by targeting multiple gut hormone receptors at once
A novel GLP-1/xenin hybrid peptide improves glucose homeostasis, circulating lipids and restores GIP sensitivity in high fat fed mice
Perhaps the answer is to hit hard for several days three or four times a year, says Horowitz
Research Resources Explore the Research Library and Research Guides for peptide science, handling, testing, storage, and quality-control resources
In vivo data were analysed with a two-way ANOVA followed by Tukeys post-hoc test (fasted glucose levels, ipGTT glucose excursion, body weight and food intake) or a one-way ANOVA followed by Dunnetts or Tukeys post-hoc test (glucose AUC, terminal fat and clinical chemistry data)
You can also take both at the same time.